Is SAGE Therapeutics Inc (SAGE) a Good Buy in the Healthcare Sector?

SAGE Therapeutics Inc (SAGE) is around the top of the Healthcare sector according to InvestorsObserver. SAGE received an overall rating of 98, which means that it scores higher than 98% of stocks. Additionally, SAGE Therapeutics Inc scored a 81 in the Healthcare sector, ranking it higher than 81% of stocks in that sector.

SAGE has an Overall Score of 98. Find out what this means to you and get the rest of the rankings on SAGE!

See Full SAGE Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 98 would rank higher than 98 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With SAGE Therapeutics Inc Stock Today?

SAGE Therapeutics Inc (SAGE) stock is trading at $50.97 as of 12:44 PM on Monday, Jun 5, a gain of $1.15, or 2.3% from the previous closing price of $49.82. The stock has traded between $49.09 and $51.03 so far today. Volume today is below average. So far 140,046 shares have traded compared to average volume of 496,565 shares. Click Here to get the full Stock Report for SAGE Therapeutics Inc stock.